Ustekinumab-Aekn 51759-0414
Product NDC
51759-0414- Manufacturer
- Teva Pharmaceuticals Usa, Inc.
- Dosage Form
- Injection, Solution
- Route
- Subcutaneous
- Product Type
- Human Prescription Drug
- Marketing Start
- December 23, 2025
- Listing Expires
- December 31, 2027
- Application
- BLA761343
Need to source Ustekinumab-Aekn? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Ustekinumab-Aekn | 90 mg/mL |
Drug Class
Interleukin-12 Antagonist [EPC]Interleukin-12 Antagonists [MoA]Interleukin-23 Antagonist [EPC]
Packaging Options(1)
1 TRAY in 1 CARTON (51759-414-32) / 1 SYRINGE, GLASS in 1 TRAY / 1 mL in 1 SYRINGE, GLASS